pdCas9-DNMT3A-PuroR (ANV) Citations (4)

Originally described in: Repurposing the CRISPR-Cas9 system for targeted DNA methylation.
Vojta A, Dobrinic P, Tadic V, Bockor L, Korac P, Julg B, Klasic M, Zoldos V Nucleic Acids Res. 2016 Mar 11. pii: gkw159. PubMed Journal

---

Articles Citing pdCas9-DNMT3A-PuroR (ANV)

Articles
Targeted DNA methylation of neurodegenerative disease genes via homology directed repair. Cali CP, Park DS, Lee EB. Nucleic Acids Res. 2019 Dec 16;47(22):11609-11622. doi: 10.1093/nar/gkz979. PubMed
DNA methylation regulates the expression of the negative transcriptional regulators ID2 and ID4 during OPC differentiation. Tiane A, Schepers M, Riemens R, Rombaut B, Vandormael P, Somers V, Prickaerts J, Hellings N, van den Hove D, Vanmierlo T. Cell Mol Life Sci. 2021 Oct;78(19-20):6631-6644. doi: 10.1007/s00018-021-03927-2. Epub 2021 Sep 5. PubMed
Host Cell Transcriptional Tuning with CRISPR/dCas9 to Mitigate the Effects of Toxin Exposure. Metzger D, Miller K, Lyon W, Migliozzi R, Pangburn HA, Saldanha R. ACS Synth Biol. 2022 Nov 18;11(11):3657-3668. doi: 10.1021/acssynbio.2c00214. Epub 2022 Nov 1. PubMed
From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions. Tiane A, Schepers M, Reijnders RA, van Veggel L, Chenine S, Rombaut B, Dempster E, Verfaillie C, Wasner K, Grunewald A, Prickaerts J, Pishva E, Hellings N, van den Hove D, Vanmierlo T. Acta Neuropathol. 2023 Aug;146(2):283-299. doi: 10.1007/s00401-023-02596-8. Epub 2023 Jun 7. PubMed

If you have published an article using this material, please email us at to have your article added to this page.